The novel IGF-IR/Akt-dependent anticancer activities of glucosamine

Ki-Hoon Song, Ju-Hee Kang, Jong-Kyu Woo

  • 1Gachon Institute of Pharmaceutical Science, Gachon University, Incheon 406-840, Republic of Korea. eyeball@hanmail.net.

BMC Cancer
|January 21, 2014
PubMed
Abstract

Insights

Glucosamine inhibits cancer cell growth by targeting the IGF-1R/Akt pathway. This natural compound reduces Insulin-like Growth Factor 1 Receptor (IGF-1R) stability, leading to cancer cell death and reduced tumor growth.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Glucosamine demonstrates inhibitory effects on various human cancer cell lines.
  • It downregulates key signaling molecules including COX-2, HIF-1α, and p70S6K.
  • The IGF-1R/Akt pathway is a known upstream regulator for these molecules, suggesting its role in glucosamine's action.

Purpose of the Study:

  • To investigate the hypothesis that glucosamine inhibits cancer cell proliferation via the IGF-1R/Akt pathway.
  • To elucidate the molecular mechanisms underlying glucosamine's anticancer activities.

Main Methods:

  • Utilized in vitro assays: flow cytometry, siRNA transfection, western blot, MTT assays, RT-PCR.
  • Employed in vivo xenograft mouse models to assess anticancer effects.
  • Investigated molecular targets including IGF-1R and Akt phosphorylation.

Main Results:

  • Glucosamine inhibited non-small cell lung cancer (NSCLC) cell growth.
  • It negatively regulated IGF-1R expression and Akt phosphorylation, decreasing IGF-1R stability via proteasomal degradation.
  • In vivo studies confirmed glucosamine's tumor growth inhibition by reducing IGF-1R signaling and increasing ER-stress.

Conclusions:

  • Targeting the IGF-1R/Akt pathway with glucosamine shows therapeutic potential for certain cancers.
  • Glucosamine's ability to induce IGF-1R degradation offers a novel strategy.
  • Further research into glucosamine as a cancer therapeutic is warranted.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K
Glycosaminoglycans01:23

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
6.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
4.3K